Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie
German professional medical society (eingetragener Verein) serving hematologists and oncologists through the Onkopedia guidelines portal (~400 articles, ~100 drug monographs), an annual conference, working groups, and educational programs, funded via membership fees and the DGHO Service GmbH subsidiary.
- Company typePrivate
- Founded1937
- HeadquartersBerlin, Germany
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie does
Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie (DGHO) is a German professional medical society (eingetragener Verein – registered association) founded in 1937 and headquartered in Berlin. It serves physicians and scientists specializing in hematology and medical oncology, functioning as Germany's leading professional body in the field and a significant voice in national healthcare policy. The organization runs 30+ working groups covering specialty topics from AI to palliative care, a quarterly member circular, and health policy publication series addressing drug shortages, demographic change, and AMNOG early benefit assessments.
DGHO's core digital asset is Onkopedia, a freely accessible guidelines portal providing diagnostic and therapeutic guidance for hematological and oncological diseases. The platform comprises a main portal with expert-developed guidelines, a parallel knowledge database of nearly 400 articles across 86 topics, a drug information system covering nearly 100 medications including AMNOG early benefit assessments and interaction/side-effect databases, and a mobile application launched in 2018 for offline access on iOS and Android. Complementary products include the eLCH eLearning Curriculum Hematology with a digitized specimen collection, the Junge DGHO youth program with mentoring and the Juniorakademie, the DGHO KI School training program on artificial intelligence, an Off-Label-Indikation database, and named scientific prizes and stipends.
The organization generates revenue primarily through annual membership fees (regulated by a separate fee schedule/Beitragsordnung), with members receiving reduced conference fees and full Onkopedia access. Additional revenue comes from conference participation and the DGHO Service GmbH subsidiary, which handles event organization, KI School, eLCH webinars, and intensive care training. The society co-organizes a joint annual conference with the Austrian (OeGHO) and Swiss (SGMO, SGH) sister societies, with the 2026 edition in Vienna attracting 806 submitted abstracts. Governance rests with a board led by Geschäftsführende Vorsitzende Prof. Dr. med. Claudia Baldus, alongside a chairman (Prof. Dr. med. Lars Bullinger) and board members.
Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie firmographics
Firmographics- Name
- Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie
- Legal name
- Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie e.V.
- Website
- https://dgho.de
- Company type
- Private
- Founded year
- 1937
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- German professional medical society (eingetragener Verein) serving hematologists and oncologists through the Onkopedia guidelines portal (~400 articles, ~100 drug monographs), an annual conference, working groups, and educational programs, funded via membership fees and the DGHO Service GmbH subsidiary.
- Ownership category
- akta.pro rank
Where Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie is headquartered
LocationHeadquarters
- HQ city
- Berlin
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Revenue model
- Membership Fees: The society generates revenue through annual membership fees. Members receive benefits including reduced conference fees, full Onkopedia access, professional information, and network access to the professional society.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Full membership with standard benefits |
Distribution channels3 records
Marketing channels5 records
Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie product offering
Product offeringCore offering
DGHO is a German professional medical society that provides clinical practice guidelines, drug information, and educational resources for hematology and medical oncology through its Onkopedia digital platform. The society also runs an annual conference, continuing medical education programs, mentoring for young professionals, and health policy advocacy for the German-speaking medical community.
Product overview
DGHO operates a unified portfolio of professional medical resources centered on Onkopedia, a comprehensive guidelines portal. The Onkopedia platform includes the main portal, a mobile app launched in 2018, a knowledge database with ~400 articles, and a drug information database covering ~100 medications. Complementing Onkopedia are educational tools (eLCH eLearning Curriculum), professional development programs (mentoring, awards, stipends), an annual conference, and an off-label indication database. The organization functions as a professional society providing clinical guidelines, educational content, and health policy resources for hematology and oncology practitioners in German-speaking regions.
Differentiator
Problem solved
Functional benefit
Brands
- Onkopedia: The guidelines portal of DGHO providing guidelines for diagnosis and therapy of hematological and oncological diseases, freely accessible
- eLCH – eLearning Curriculum Hämatologie
- Junge DGHO
- DGHO KI School
- Deutsche Stiftung für junge Erwachsene mit Krebs
Products and services
- Onkopedia
Companies that use Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie
Customer profileSegments1 record
Ideal customer profiles1 record
Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core.
- OeGHO (Österreichische Gesellschaft für Hämatologie und Medizinische Onkologie)coreAustrian sister society co-organizing the joint annual conference. The 2026 annual conference in Vienna is a common congress of DGHO, OeGHO, SGMO (Swiss), and SGH, making it a major European hematology-oncology event.
- SGMO (Schweizerische Gesellschaft für Medizinische Onkologie)coreSwiss Society for Medical Oncology co-organizing the joint annual conference with DGHO, OeGHO, and SGH.
- SGH (Schweizerische Gesellschaft für Hämatologie)coreSwiss Society for Hematology co-organizing the joint annual conference with DGHO, OeGHO, and SGMO.
- DGHO Service GmbHcoreA service company of DGHO located at the same Berlin office, providing additional services including event organization (KI School, eLCH webinars, intensive care training courses). Website: dgho-service.de
Scale indicators3 records
Recent moves6 records
Expansion highlights6 records
Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie competitors and assessment
Company assessmentDirect peers
- American Society of Clinical Oncology (ASCO): Largest US-based professional society for oncology, publishing clinical guidelines, hosting ASCO Annual Meeting, and operating JCO/JCO Oncology Practice journals. Direct functional peer to DGHO in guideline publishing, conference organization, and member education for oncology professionals.
- European Society for Medical Oncology (ESMO): Leading European oncology society publishing clinical practice guidelines, hosting the ESMO Congress, and serving medical oncologists across Europe. Most directly comparable continental peer to DGHO in oncology guideline development, education, and congress operations.
- European Hematology Association (EHA): European hematology society that publishes guidelines, hosts the EHA Congress, and provides educational programs across Europe. Directly mirrors DGHO's hematology mission with a pan-European footprint, making it both a peer and partial competitor for content and congress share.
- American Society of Hematology (ASH): Premier global hematology society producing clinical guidelines, publishing Blood, and hosting the ASH Annual Meeting. Closest peer to DGHO for the hematology half of its scope, with similar content, conference, and advocacy offerings.
Broad incumbents
- International Society of Hematology (ISH): Global hematology society that organizes biennial World Congress and supports hematology education worldwide. Broader geographic scope than DGHO but similar professional-society function for hematologists.
- National Comprehensive Cancer Network (NCCN): US-based alliance of leading cancer centers that produces widely adopted oncology clinical practice guidelines used globally. Comparable to Onkopedia as a guidelines publisher but operates as a guideline consortium rather than a member-driven professional society.
Others
- European Medicines Agency (EMA): EU regulator referenced extensively in Onkopedia drug information entries. Not a competitor but a key external data source whose labeling decisions feed directly into DGHO's drug information and AMNOG assessments.
- Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF): German umbrella association of medical scientific societies that coordinates S3 guideline development across specialties. DGHO participates in AWMF's guideline infrastructure, making AWMF both an enabler of DGHO's guideline work and an indirect collaborator/peer at the meta-society level.
Regional players
- Österreichische Gesellschaft für Hämatologie und Medizinische Onkologie (OeGHO): Austrian sister society of DGHO with overlapping mission and joint annual conference co-organization. Functionally identical in structure (professional society, guidelines, congress) but scoped to Austria rather than Germany.
- British Society for Haematology (BSH): UK national hematology society producing clinical guidelines, hosting the BSH Annual Scientific Meeting, and providing member education. Comparable to DGHO's hematology half but UK-focused rather than German.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie social profiles
Digital presenceDeutsche Gesellschaft für Hämatologie und Medizinische Onkologie financial estimates
Financial estimateRevenue estimate
Valuation estimate
Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie leadership team
Management profileNumber of profiles
Profiles4 records
Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie subsidiaries and ownership
Company hierarchySubsidiaries1 record
Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie
What does Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie do?
DGHO is a German professional medical society that provides clinical practice guidelines, drug information, and educational resources for hematology and medical oncology through its Onkopedia digital platform. The society also runs an annual conference, continuing medical education programs, mentoring for young professionals, and health policy advocacy for the German-speaking medical community.
Is Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie a public or private company?
Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie founded?
Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie was founded in 1937. It employs 1 to 10 people.
Where is Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie based?
Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie is headquartered in Berlin, Germany, in the Europe region.
How does Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie make money?
One revenue line is on record: membership Fees.
Who are Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie's main competitors?
Direct peers on record are American Society of Clinical Oncology (ASCO), European Society for Medical Oncology (ESMO), European Hematology Association (EHA) and American Society of Hematology (ASH). Broad incumbents are International Society of Hematology (ISH) and National Comprehensive Cancer Network (NCCN). Others are European Medicines Agency (EMA) and Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). Regional players are Österreichische Gesellschaft für Hämatologie und Medizinische Onkologie (OeGHO) and British Society for Haematology (BSH).
Does Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie have an API?
No public API is recorded for Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie.